Negotiations between Britain and existing members of the CPTPP have been taking place since September 2021.
Australia’s Therapeutic Goods Administration has given provisional approval to Moderna’s bivalent Covid vaccine designed to target both the Omicron variant of the virus and the original Covid strain.